In one five-year period, college athletes suffered more than 10,000 concussions — one-third of them while playing football. But an unusual team-up has recently brought a new, biomarker-based concussion test one step closer.
Pancreatic cancer is the fourth leading cause of cancer deaths in the United States each year, in part because around four-fifths of cases go undetected until they have reached an advanced stage. But a new, biomarker-based test could soon change all that — and offer a way to monitor treatment outcomes.